Immuron Limited
IMRN · NASDAQ
6/30/2025 | 3/31/2025 | 12/30/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 100% | -58.8% | 100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 64% | 64% | 66.5% | 66.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -86.6% | -84.9% | -63.5% | -63.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -84% | -82.8% | -62.3% | -62.3% |
| EPS Diluted | -0.47 | -0.23 | -0.43 | -0.22 |
| % Growth | -104.3% | 46.5% | -95.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |